Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XPY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025. The delivery order is for Stelara 90 mg/ml syringes, with an ultimate completion date of August 22, 2025. This award carries no set-aside designation, allowing the vendor to compete on its merits within the broader federal procurement marketplace. The contract represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, particularly for military health facilities. The company's comprehensive portfolio includes branded and generic prescription medications, biologics, and medical consumables distributed to Department of Defense healthcare sites nationwide. This delivery order for Stelara, an immunosuppressant biologic used to treat conditions such as psoriasis and inflammatory bowel disease, exemplifies the company's role in providing specialized pharmaceutical products essential to federal healthcare operations. The firm fixed-price structure and short completion window reflect the Defense Logistics Agency's need for reliable, expedited pharmaceutical supply fulfillment.
Quick answers
Who was awarded contract SPE2DX25F6XPY?
SPE2DX25F6XPY was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 1, 2025.
How much is contract SPE2DX25F6XPY worth?
The government has obligated $16,250 on SPE2DX25F6XPY.
Is contract SPE2DX25F6XPY an order under another contract?
Yes. SPE2DX25F6XPY is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XPY competed?
The extent of competition for SPE2DX25F6XPY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award